Search search Menu Home Our Products Dermal Dermal Convenient for patients, protective for formulations The dermal application is a convenient non-invasive way to administer liquid sprays, lotions, gels, or creams to the skin for dermatological, anti-inflammatory or systemic treatments. Our airless and atmospheric delivery devices are suitable for RX and OTC formulations and have all the documentation needed to be registered on regulated markets. All Commercially available In development/Research Tailor-made for customers Sof’Bag+ Sof’Bag+ is an airless pouch-in-bottle packaging solution for prescription (Rx) and over-the-counter (OTC) formulations for dermal and transdermal application. Discover More Sof’Airless XS+ Sof’Airless XS+ is a protective mini-airless system to deliver gel and creams for small dose applications and sampling. Discover More Spray pumps for viscous formulations We provide a wide range of atmospheric pumps to deliver your liquid and viscous formulations in a comprehensive range of doses. Discover More (CRC) Child Resistant Closure for dermal devices The Child Resistant Closure for Sof’Bag® is a ‘press and turn’ concept developed to prevent unwanted child opening while making it easy to manipulate for adults. Discover More Our services Integrated services from device selection to GMP manufacturing We have developed end-to-end services and expertise in dermal drug delivery device development and device consulting, to complement our diverse portfolio of products and help you through every step of the journey. Discover more Early-stage Innovation We provide a full understanding of the patient journey and recommend user-related activities to further optimize patients’ experience for a specific drug/device combination product. Discover more Testing services for customer formulations Thanks to our high-end laboratory facilities, we propose device plus formulation test services, as well as test methods development for our customers’ needs. More about Nemera Knowledge Hub Cutting-edge insights, resources, press articles, and webinars to learn more about the holistic ecosystem of drug delivery device solutions. Discover more Who we are We design and manufacture devices that maximize treatment efficacy and partner with our customers in their device strategies, to ultimately bring high-quality and safe treatment solutions to patients. Discover more FAQ What conditions are Nemera’s dermal devices used for? Our systems aim to be used for all diseases for which the treatments can be administered via the skin: Hormonal disorders (hypogonadisms or menopausal symptoms) Psoriasis, an autoimmune disease that causes inflammation in the body, consisting of red, scaly plaques occurring most commonly on the elbows, knees, scalp, and lower back, but any skin surface can be involved. Psoriasis is estimated to affect 2–4% of the population of the western world. Eczema, a common chronic or recurrent inflammatory skin disease characterized by acute flare-ups of eczematous pruritic lesions over dry skin. It affects 15-20% of children and 1-3% of adults worldwide. Acne, a common chronic skin disease involving blackheads or whiteheads, pimples, oily skin, and possible scarring. Acne is estimated to affect 9.4% of the global population, making it the eighth-most prevalent disease worldwide. Hair loss. Topical pain, like painful muscles or joints. Given most of these treatments are self-administered by the patient, convenience such as 360-degree usage and safety are important criteria to increase compliance rates. What is an airless system? Why choose airless systems? What is the difference between an airless pouch-in-bottle and an airless piston technology? Our product catalogue Dermal Download Get in touch Get in touch to find out more about us, our solutions and what we can do for you. If you’re looking for job opportunities, please visit: Join Our Team First Name*: Last Name*: Company Name*: Job Title*: State: Country*: Please select... Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d'Ivoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard and Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao, People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe Email*: Phone: Main Interest*: Please select... Our Services Our Products Other Channel (how did you hear about us?)*: Please select... Search Engine Social Media Website Exhibitions Press Word of Mouth Third party network Other Message*: Your personal data is intended for Nemera and its subsidiaries to process your request for information. You have rights over your personal data, such as the right to access, erase and object. For more information, see our Privacy Policy. * Required fields. LinkedIn Twitter Youtube Who We Are Privacy Policy Cookies policy Legal Policy 20 Avenue de la Gare 38290 La Verpillière - France T. +33 4 74 94 06 54 © 2021 Nemera. Website developed by Illustrate Digital